1. Jiang F#, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C*. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol. 2014 Jul;11(7):413-26. (IF: 49.421)
2. Tian Z#, Zhang Y, Zheng Z, Zhang M, Zhang T, Jin J, Zhang X, Yao G, Kong D, Zhang C*, Wang Z*, Zhang Q*. Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation. Cell Host Microbe. 2022 Oct 12;30(10):1450-1463.e8. (IF: 31.316)
3. Xue F#, Cheng J#, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P*, Zhang Y*, Zhang C*. Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther. 2022 Aug 1;7(1):259.(IF: 38.104)
4. Yu L#, Zhang J, Gao A, Zhang M, Wang Z, Yu F, Guo X, Su G, Zhang Y, Zhang M*, Zhang C*. An intersegmental single-cell profile reveals aortic heterogeneity and identifies a novel Malat1+ vascular smooth muscle subtype involved in abdominal aortic aneurysm formation. Signal Transduct Target Ther. 2022 Apr 27;7(1):125.(IF: 38.104)
5. Jin J#, Gao L#, Zou X#, Zhang Y, Zheng Z, Zhang X, Li J, Tian Z, Wang X, Gu J, Zhang C*, Wu T*, Wang Z*, Zhang Q*. Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts. Circ Res. 2022 Sep 2;131(6):492-506. (IF: 23.213)